INOVIO’s ASCO and ASGCT updates may sharpen scrutiny of its DNA medicine strategy
INOVIO has a regulatory clock ticking. New INO-3107 and hemophilia A data may show whether its DNA platform can move beyond promise.
INOVIO has a regulatory clock ticking. New INO-3107 and hemophilia A data may show whether its DNA platform can move beyond promise.